Key findings from the new studies: ARTIOS trial: Patients who switched to Kesimpta after experiencing relapses or MRI activity on other oral treatments showed fewer relapses, suppressed MRI activity, and over 90% achieved no evidence of disease activity (NEDA-3)
Bermans process is designed to be clear, supportive, and centered around you
As efficacy benchmarks rise, the real differentiator may not be who builds the most complex molecule but who can execute across that complexity (trial design, patient stratification, safety signaling, real-world validation)
Factors That Can Reduce Ozempic's Effectiveness Whilst Ozempic generally maintains its therapeutic efficacy over extended periods, several factors can influence an individual's response to treatment or create the impression that the medication is no longer working as effectively
Skin tone and pigmentation are influenced by sun exposure, hormones, inflammation, and ageing